Acute pancreatitis related to therapeutic dosing with colchicine: a case report.
BACKGROUND
Colchicine is used in the treatment and prophylaxis of gout. It possesses a narrow therapeutic window, frequently resulting in dose-limiting gastrointestinal side-effects such as diarrhoea and emesis. As colchicine is a cellular anti-mitotic agent, the most serious effects include myelosuppression, myoneuropathy and multiple organ failure. This occurs with intentional overdose or with therapeutic dosing in patients with reduced clearance of colchicine due to pre-existing renal or hepatic impairment. Acute pancreatitis has rarely been reported, and only in association with severe colchicine overdose accompanied by multi-organ failure.


METHODS
We report a case of acute pancreatitis without other organ toxicity related to recent commencement of colchicine for acute gout, occurring in an elderly male with pre-existing renal impairment.


CONCLUSIONS
1) Colchicine should be used with care in elderly patients or patients with impaired renal function.2) Aside from myelosuppression, myoneuropathy and multiple organ failure, colchicine may now be associated with acute pancreatitis even with therapeutic dosing; this has not previously being reported.
Ting
Joseph Yuk Sang
JY
Department of Emergency Medicine, Mater Adult Hospital, Raymond Tce, South Brisbane 4101, Australia. jysting@uq.edu.au.
N Engl J Med. 2003 Oct 23;349(17):1647-55
14573737
Wien Klin Wochenschr. 2004 Mar 31;116(5-6):205-8
15088997
Gastroenterology. 2005 Mar;128(3):756-63
15765410
N Engl J Med. 2006 May 18;354(20):2142-50
16707751
Drugs. 2006;66(12):1547-63
16956303
J Anal Toxicol. 1991 May-Jun;15(3):151-4
1943060
Drug Saf. 1996 Jun;14(6):406-23
8828018
J Am Osteopath Assoc. 1982 Dec;82(4):252-4
7153075
J Toxicol Clin Toxicol. 1995;33(1):71-7
7530779
Ther Hung. 1993;41(2):72-7
8278942
Arch Intern Med. 1977 Mar;137(3):394-6
843157
Pancreas. 1996 Jul;13(1):22-8
8783330
Scand J Gastroenterol. 1977;12(1):17-20
319521